Case study a case study of delayed serotonin syndrome: Lessons learned

Consultant Pharmacist

Volumn 24, Issue 1, 2009, Pages 64-68

  Pearce, Shannon ^a   Ahmed, Nasiya ^a   Varas, Grace M ^a  

^a UNIVERSITY OF TEXAS   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMLODIPINE; BENZODIAZEPINE; BUSPIRONE; CREATINE KINASE; DEXTROMETHORPHAN; DONEPEZIL; INFUSION FLUID; LINEZOLID; LORAZEPAM; METOCLOPRAMIDE; MIRTAZAPINE; MONOAMINE OXIDASE INHIBITOR; PARACETAMOL; PAROXETINE; PETHIDINE; SELEGILINE; SEROTONIN; SEROTONIN UPTAKE INHIBITOR; TRAMADOL; TRIPTAN DERIVATIVE; TRYPTOPHAN; ALPHA ADRENERGIC RECEPTOR BLOCKING AGENT; DRUG DERIVATIVE; MIANSERIN;

AFRICAN AMERICAN; AGED; AGITATION; ANTIBIOTIC THERAPY; ARTICLE; ASSISTED LIVING FACILITY; CASE REPORT; CHILL; CONFUSION; CREATINE KINASE BLOOD LEVEL; DECREASED APPETITE; DELIRIUM; DEPRESSION; DIAGNOSTIC APPROACH ROUTE; DISEASE ASSOCIATION; DISEASE COURSE; DRUG WITHDRAWAL; EMERGENCY WARD; FEMALE; HUMAN; HYPERTHERMIA; MENTAL HEALTH; PATHOPHYSIOLOGY; PHYSICAL EXAMINATION; PRACTICE GUIDELINE; SEROTONIN SYNDROME; URINE INCONTINENCE; CHEMICALLY INDUCED DISORDER; DRUG INTERACTION; TIME;

ADRENERGIC ALPHA-ANTAGONISTS; AGED; ASSISTED LIVING FACILITIES; DRUG INTERACTIONS; FEMALE; HUMANS; MIANSERIN; PAROXETINE; SEROTONIN SYNDROME; SEROTONIN UPTAKE INHIBITORS; TIME FACTORS;

EID: 59049103982     PISSN: 08885109     EISSN: None     Source Type: Journal    
DOI: 10.4140/TCP.n.2009.64     Document Type: Article

References (21)

1. Sternbach H. The serotonin syndrome. Am J Psychiatry 1991;148:705-13.
2. Boyer EW, Shannon M. The serotonin syndrome. N Engl J Med 2005;352:.1112-20.
3. Dvir Y, Smallwood P. Serotonin syndrome: a complex but easily avoidable condition. Gen Hosp Psychiatry 2008;30: 284-7.
4. Paruchuri P, Godkar D, Anadacoomarswamy D et al. Rare case of serotonin syndrome with therapeutic doses of paroxetine. Am J Therap 2006;13:550-2.
5. Birmes P, Coppin D, Schmitt L et al. Serotonin syndrome: a brief review. CMAJ 2003;168:1439-2.
6. Lane R, Baldwin D. Selective serotonin reuptake inhibitorinduced serotonin syndrome: review. J Clin Psychopharm 1997;17:208-21.
7. Nieuwstraten C, Labiris NR, Holbrook A. Systematic overview of drug interactions with antidepressant medications. Can J Psychiatry 2006;51:300-16.
8. Phillippe B, Coppin D, Schmitt L et al. Serotonin syndrome: a brief review. Can Med Assoc J 2003; 168:1439-42.
9. Ubogu EE, Katirji B. Mirtazapine-induced serotonin syndrome. Clin Neuropharmacol 2003;26:54-7.
10. Mackay F, Dunn N, Mann R. Antidepressants and the serotonin syndrome in general practice. Br J Gen Pract 1999;49:871-4.
11. Naranjo C, Busto U, Sellers E. A method for estimating the probability of adverse drug reactions. Clin Pharmacol Ther 1981;39:239-4S.
12. Serotonin syndrome. Pharmacist Lett Prescriber Lett 2006;22:220905.
13. Mason P, Morris V, Balcezak T. Serotonin syndrome: presentation of 2 cases and review of the literature. Medicine 2000;79:201-9.
14. Antonio J, Morales-Molina J, Marin-Casino M et al. Linezolidassociated serotonin syndrome: what we can learn from cases so far. J Antimicrob Chemother 2005;56:1176-8.
15. Martin T. Serotonin syndrome. Ann Emerg Med 1996;28:520-6.
16. Sheline Y, Mintun M, Moerlin S et al. Greater loss of 5-HT2A receptors in midlife than in late life. Am J Psychiatry 2002; 159:430-5.
17. Guyton A, Hall J, eds. Organization of the nervous system: basic functions of synapses and neurotransmitter substances. In Textbook of Medical Physiology. 10th ed. Philadelphia, PA: Interamericana McGraw-Hill; 2001.
18. Isbister G, Buckley N,Whyte I. Serotonin toxicity: a practical approach to diagnosis and treatment. Med J Aust 2007; 187:361-5.
19. Dunkley E, Isbister G, Sibbritt D et al. The Hunter Serotonin Syndrome Toxicity Criteria: simple and accurate diagnostic decision rules for serotonin toxicity. QJ Med 2003;96:635-42.
20. Radomski J, Dursun S, Reveley M. Toxic serotonin syndrome: an update and revised diagnostic criteria. JPsychopharmacol 1995;9:A21.
21. FDA. Med Watch. Adverse Event Reporting Surveillance [Information for health care professionals to voluntarily report adverse medication events]. Available at http://www.fda.gov/medwatch/. Accessed May 22, 2008.